Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China
· Delayed Price · Currency is CNY 27.83
+0.08 (0.29%)
At close: Mar 9, 2026
SHA:600566 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 25,641 | 26,803 | 28,972 | 25,092 | 25,173 | 17,969 | Upgrade
|
| Market Cap Growth | 3.26% | -7.49% | 15.47% | -0.32% | 40.09% | -8.81% | Upgrade
|
| Enterprise Value | 15,462 | 16,353 | 19,711 | 18,865 | 20,556 | 14,633 | Upgrade
|
| Last Close Price | 27.83 | 26.98 | 28.12 | 23.62 | 23.88 | 16.65 | Upgrade
|
| PE Ratio | 15.48 | 10.59 | 10.26 | 11.56 | 14.64 | 14.07 | Upgrade
|
| Forward PE | - | 8.82 | 11.02 | 11.16 | 13.64 | 11.87 | Upgrade
|
| PS Ratio | 4.17 | 3.34 | 3.00 | 2.79 | 3.30 | 2.92 | Upgrade
|
| PB Ratio | 1.85 | 1.82 | 2.17 | 2.21 | 2.76 | 2.32 | Upgrade
|
| P/TBV Ratio | 1.92 | 1.88 | 2.25 | 2.31 | 2.90 | 2.46 | Upgrade
|
| P/FCF Ratio | 24.69 | 13.39 | 9.16 | 10.56 | 15.29 | 13.29 | Upgrade
|
| P/OCF Ratio | 22.48 | 12.32 | 8.36 | 9.57 | 13.29 | 10.09 | Upgrade
|
| PEG Ratio | - | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | Upgrade
|
| EV/Sales Ratio | 2.52 | 2.04 | 2.04 | 2.10 | 2.69 | 2.37 | Upgrade
|
| EV/EBITDA Ratio | 7.89 | 6.00 | 6.19 | 7.37 | 10.47 | 8.78 | Upgrade
|
| EV/EBIT Ratio | 9.34 | 6.74 | 6.84 | 8.37 | 12.31 | 10.56 | Upgrade
|
| EV/FCF Ratio | 14.89 | 8.17 | 6.23 | 7.94 | 12.49 | 10.82 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.06 | 0.08 | 0.04 | 0.07 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.37 | 0.31 | 0.34 | 0.16 | 0.32 | 0.36 | Upgrade
|
| Debt / FCF Ratio | 0.70 | 0.42 | 0.35 | 0.17 | 0.38 | 0.45 | Upgrade
|
| Net Debt / Equity Ratio | -0.74 | -0.75 | -0.73 | -0.66 | -0.53 | -0.47 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.21 | -4.03 | -3.08 | -2.91 | -2.48 | -2.17 | Upgrade
|
| Net Debt / FCF Ratio | -9.83 | -5.49 | -3.11 | -3.14 | -2.95 | -2.67 | Upgrade
|
| Asset Turnover | 0.35 | 0.44 | 0.58 | 0.66 | 0.67 | 0.64 | Upgrade
|
| Inventory Turnover | 2.77 | 3.15 | 4.05 | 4.01 | 3.90 | 3.66 | Upgrade
|
| Quick Ratio | 5.16 | 3.99 | 2.99 | 3.13 | 2.75 | 3.18 | Upgrade
|
| Current Ratio | 5.32 | 4.16 | 3.10 | 3.26 | 2.90 | 3.34 | Upgrade
|
| Return on Equity (ROE) | 11.83% | 18.06% | 22.87% | 21.20% | 20.33% | 18.42% | Upgrade
|
| Return on Assets (ROA) | 5.97% | 8.28% | 10.88% | 10.39% | 9.22% | 9.03% | Upgrade
|
| Return on Invested Capital (ROIC) | 39.55% | 56.78% | 66.53% | 47.85% | 34.95% | 28.55% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.70% | 16.30% | 21.30% | 19.50% | 17.90% | 16.20% | Upgrade
|
| Earnings Yield | 6.44% | 9.45% | 9.74% | 8.65% | 6.83% | 7.11% | Upgrade
|
| FCF Yield | 4.05% | 7.47% | 10.91% | 9.47% | 6.54% | 7.52% | Upgrade
|
| Dividend Yield | 7.53% | 7.75% | 4.62% | 3.73% | 2.85% | 2.70% | Upgrade
|
| Payout Ratio | 116.50% | 48.10% | 29.16% | 27.89% | 23.81% | 78.98% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | -0.08% | -0.91% | -0.91% | -7.82% | -2.36% | Upgrade
|
| Total Shareholder Return | 7.58% | 7.66% | 3.72% | 2.82% | -4.98% | 0.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.